2025年12月17日，“Nature Reviews Drug Discovery”杂志发表文章，分析了目前在研的，以及自2011年以来获批的抗癌药物的靶点。数据显示，多数晚期肿瘤药物不具备新颖靶点，且潜在first-in-class药物的占比通常与研发阶段呈负相关。

MEXICO CITY, Jan. 5 (Xinhua) -- Mexican President Claudia Sheinbaum on Monday rejected the possibility of U.S. intervention in Mexico to combat drug cartels, stressing the importance of maintaining ...

综合来看，这篇论文认为，如果AI药物在I期和II期的高成功率能够持续，并与传统药物在III期的成功率相结合，那么新药的研发成功率将从目前的5-10%提高到9-18%，制药行业的整体研发效率将实现翻倍。

KABUL, Jan. 5 (Xinhua) -- Afghan security forces have uncovered and dismantled a drug manufacturing facility in southern Helmand province, arresting 20 individuals in connection with the case, ...

Insilico Medicine, an artificial intelligence-driven drug discovery company backed by Qiming Venture Partners, made its debut ...